Cargando…
Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs?
Autores principales: | Milojevic, Milan, Nikolic, Aleksandar, Micovic, Slobodan, Jeppsson, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252115/ https://www.ncbi.nlm.nih.gov/pubmed/35522014 http://dx.doi.org/10.1093/icvts/ivac112 |
Ejemplares similares
-
Are NOACs as safe and efficient as VKA regarding thromboembolic prophylaxis and major bleeding in patients with surgical bioprosthesis and atrial fibrillation within 3 months of surgery?
por: Magro, Pedro Lamares, et al.
Publicado: (2022) -
Successful surgical aortic valve replacement in a patient with progeria
por: Vukovic, Petar, et al.
Publicado: (2022) -
Standalone epicardial left atrial appendage exclusion for thromboembolism prevention in atrial fibrillation
por: Cartledge, Richard, et al.
Publicado: (2021) -
Associations between new-onset postoperative atrial fibrillation and long-term outcome in patients undergoing surgical aortic valve replacement
por: Rezk, Mary, et al.
Publicado: (2023) -
Results of concomitant cryoablation for atrial fibrillation during mitral valve surgery
por: Bogachev-Prokophiev, Alexander, et al.
Publicado: (2021)